Kymera Therapeutics, Inc. · NASDAQ:KYMR

Booth Bruce sold 31,283 Kymera Therapeutics, Inc. shares (Form 4)

Traded Jun 29, 2026 · Filed Jun 30, 2026

On Jun 29, 2026, Booth Bruce (Director) sold 31,283 Kymera Therapeutics, Inc. shares at an average US$109.48 for US$3.42M under a trading plan, leaving 461,794 shares. Filed Jun 30, 2026 (Form 4).

Sold: 31,283 shares
Price: US$109.48 average (US$108.28 to US$111.20)
Value: US$3.42M
Holding after: 461,794 shares (held indirectly)
Trading plan: Yes (Made under a plan set in advance)
Role: Director

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jun 29, 2026	Common Stock	Sale	10,658	US$108.28	2,402,089	Indirect
Jun 29, 2026	Common Stock	Sale	7,833	US$109.75	2,394,256	Indirect
Jun 29, 2026	Common Stock	Sale	7,602	US$110.67	2,386,654	Indirect
Jun 29, 2026	Common Stock	Sale	907	US$111.20	2,385,747	Indirect
Jun 29, 2026	Common Stock	Sale	1,688	US$108.28	464,389	Indirect
Jun 29, 2026	Common Stock	Sale	1,239	US$109.75	463,150	Indirect
Jun 29, 2026	Common Stock	Sale	1,199	US$110.67	461,951	Indirect
Jun 29, 2026	Common Stock	Sale	157	US$111.20	461,794	Indirect

Source

View original at SEC

Related